(Q84587023)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21782575%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Antioxidants in critical care medicine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21782575%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

N A Coleman

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21782575%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

1 September 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21782575%20AND%20SRC:MED&resulttype=core&format=json

Environmental Toxicology and Pharmacology

8 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21782575%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21782575%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21782575%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

183-188

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21782575%20AND%20SRC:MED&resulttype=core&format=json

Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome.

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord I

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors.

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

Effect of 21-aminosteroid on extracellular energy-related metabolites and amino acids after compression injury of rat spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

Circulatory volume expansion for aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

Induction of tirilazad clearance by phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

Selenium, systemic immune response syndrome, sepsis, and outcome in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

Effects of the 21-aminosteroid U74006F on experimental head injury in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

21-Aminosteroid lipid peroxidation inhibitor U74006F protects against cerebral ischemia in gerbils

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

Blocking Weight-Induced Spinal Cord Injury in Rats: Therapeutic Effect of the 21-Aminosteroid U74006F

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

Effect of age and gender on tirilazad pharmacokinetics in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: a prospective, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

Measures of total free radical activity in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

Effect of the 21-aminosteroid tirilazad on cerebral pH and somatosensory evoked potentials after incomplete ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

Conference summary: acute lung injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

The novel 21-aminosteroid U74006F attenuates cerebral edema and improves survival after brain injury in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

Antioxidant status in patients with acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

Tirilazad mesylate protects vitamins C and E in brain ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study.

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

Oxidative metabolism of circulating granulocytes in adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

A randomized trial of tirilazad mesylate in patients with acute stroke (RANTTAS). The RANTTAS Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1382-6689%2801%2900082-5

7 January 2021

10.1016/S1382-6689(01)00082-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21782575%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference